Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
13.81
-0.15 (-1.07%)
Range 13.69 - 14.39
Open 14.10
Prev Close 13.96
52 Week 6.75 - 15.79
Volume 568064
Market Cap 1.43B
*Delayed 4/29/2016 4:00 EDT

 
Form 8937 for 2015 Reverse Stock Split

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000